ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
6,073.92
0.40%
US Tech 100
20,863.20
0.91%
다우존스 지수
44,903.24
0.44%
Bitcoin
96,319.98
0.36%
Registration Strip Icon for monitor 브라질 증권 거래소, NASDAQ, NYSE, AMEX, LSE 등 주요 거래소에서의 다양한 실시간 주식 시세를 모니터링합니다.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ

  6. Zymergen Inc (ZY) 시세

Zymergen Inc

Zymergen Inc (ZY)

NASDAQ
2.43
0.00
( 0.00% )
업데이트: 09:00:00
15분 지연

개인 투자자를 위한 전문가급 도구.

프리미엄

주요 통계 및 세부정보

가격
2.43
매수가
2.30
매도가
2.31
거래량
-
0.00 일간 변동폭 0.00
0.00 52주 범위 0.00
전일 종가
2.43
개장가
-
최근 거래 시간
마지막 거래 시간
-
평균 볼륨(3m)
-
재정 규모
-
VWAP
-

ZY 최신 뉴스

추가 뉴스

Ginkgo Bioworks Completes Acquisition of Zymergen

Ginkgo Bioworks Completes Acquisition of Zymergen PR Newswire BOSTON and EMERYVILLE, Calif., Oct. 19, 2022 BOSTON and EMERYVILLE, Calif., Oct. 19, 2022 /PRNewswire/ -- Today, Ginkgo Bioworks...

19 10월 2022
PR Newswire (US)

Ginkgo to Acquire Zymergen

Ginkgo to Acquire Zymergen PR Newswire BOSTON and EMERYVILLE, Calif., July 25, 2022 Acquisition is expected to accelerate the development of Ginkgo's innovative horizontal synthetic biology...

25 7월 2022
PR Newswire (US)

Zymergen Expands Agreement with Octant to Scale Next-Generation Drug Discovery Platform

EMERYVILLE, Calif., July 14, 2022 (GLOBE NEWSWIRE) -- Zymergen Inc. (“Zymergen” or the “Company”) today announced it has expanded its agreement with Octant to further scale their next-generation...

15 7월 2022
GlobeNewswire Inc.

Zymergen Announces R&D Supply Agreement with 3D4Makers to Provide New Polyimide for Use in High-Performance 3D Printing Applications

EMERYVILLE, Calif., June 28, 2022 (GLOBE NEWSWIRE) -- Zymergen Inc. (“Zymergen” or the “Company”) today announced an R&D supply agreement to provide Zymergen Z2TM polyimide powder to...

29 6월 2022
GlobeNewswire Inc.

Zymergen Sells Modular Automation System to Octant to Scale Next-Generation Drug Discovery Platform

EMERYVILLE, Calif., May 26, 2022 (GLOBE NEWSWIRE) -- Zymergen Inc. (“Zymergen” or the “Company”), today announced it has entered into an agreement with Octant for the sale of a modular...

27 5월 2022
GlobeNewswire Inc.

Senti Bio Secures Additional Financing from Leaps by Bayer and Provides Update on Proposed Business Combination with Dynamics Special Purpose Corp. (DYNS)

- Leaps by Bayer led Series B investment in Senti Bio in 2021; Additional Convertible Note financing expands committed capital to PIPE investment associated with previously announced Business...

24 5월 2022
GlobeNewswire Inc.

Zymergen Reports Preliminary First Quarter 2022 Financial Results

EMERYVILLE, Calif., May 12, 2022 (GLOBE NEWSWIRE) -- Biotechnology company Zymergen Inc. (“Zymergen” or the “Company”), today reported preliminary financial results for the first quarter ended...

13 5월 2022
GlobeNewswire Inc.

Zymergen to Participate in the BofA Securities 2022 Healthcare Conference

EMERYVILLE, Calif., April 29, 2022 (GLOBE NEWSWIRE) -- Zymergen Inc. (“Zymergen” or the “Company”), today announced the company will be participating in the upcoming BofA Securities 2022...

29 4월 2022
GlobeNewswire Inc.

Zymergen to Report Preliminary First Quarter 2022 Financial Results on May 12, 2022

EMERYVILLE, Calif., April 13, 2022 (GLOBE NEWSWIRE) -- Zymergen Inc. (“Zymergen” or the “Company”) today announced it will report preliminary financial results for the first quarter 2022 after...

14 4월 2022
GlobeNewswire Inc.

Zymergen Reports Preliminary Fourth Quarter and Full Year 2021 Financial Results

EMERYVILLE, Calif., March 22, 2022 (GLOBE NEWSWIRE) -- Biotechnology company Zymergen Inc. (“Zymergen” or the “Company”), today reported preliminary financial results for the fourth quarter and...

23 3월 2022
GlobeNewswire Inc.
기간변동변동 %시가고가저가평균 일일 거래량VWAP
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

이동자

모두 보기
  • 가장 활성
  • % 상승자
  • % 패자
기호가격볼륨
CYCNCyclerion Therapeutics Inc
US$ 7.2136
(348.05%)
115.72M
SMXSMX Security Matters Public Company
US$ 0.512549
(163.12%)
457.13M
CNEYCN Energy Group Inc
US$ 0.593026
(87.90%)
155.23M
SRMSRM Entertainment Inc
US$ 1.1208
(77.88%)
133.89M
HTOOFusion Fuel Green PLC
US$ 0.559
(75.79%)
267.09M
RLMDRelmada Therapeutics Inc
US$ 0.643
(-76.79%)
14.06M
MIGIMawson Infrastructure Group Inc
US$ 0.8422
(-55.91%)
10.9M
MONDMondee Holdings Inc
US$ 0.1998
(-32.29%)
2.58M
ORISOriental Rise Holdings Ltd
US$ 8.48
(-29.04%)
507.23k
FGLFounder Group Limited
US$ 2.95
(-27.70%)
9.79M
SMXSMX Security Matters Public Company
US$ 0.512549
(163.12%)
457.13M
SVMHSRIVARU Holding Ltd
US$ 0.0267
(21.36%)
438.3M
HTOOFusion Fuel Green PLC
US$ 0.559
(75.79%)
267.09M
CNEYCN Energy Group Inc
US$ 0.593026
(87.90%)
155.23M
SRMSRM Entertainment Inc
US$ 1.1208
(77.88%)
133.89M

ZY Discussion

게시물 보기
janice shell janice shell 3 월 전
I know. I just posted to the last person who'd had something to say about this company.
👍️0
Triple nickle Triple nickle 3 월 전
My post date was 2022
👍️0
janice shell janice shell 3 월 전
What date? The complaint was filed in federal court today.
👍️0
Triple nickle Triple nickle 3 월 전
Check that date
👍️0
janice shell janice shell 3 월 전
fwiw:

SEC Charges Zymergen Inc. With Misleading IPO Investors About Company’s Market Potential and Sales Prospects

https://www.sec.gov/newsroom/press-releases/2024-129

The Complaint:

https://www.sec.gov/files/litigation/admin/2024/33-11303.pdf
👍️0
Triple nickle Triple nickle 3 년 전
About time here
👍️0
Wake Setter Wake Setter 3 년 전
Still a great opportunity here. Once all the law firms quit spamming the news wires for ZY and the company gives new guidance we could see some steps up.

$8.40 was a gift from God
👍️0
$treet $inatra $treet $inatra 3 년 전
great pop and even greater upside for the longer term holders, congrats!
👍️0
JstnDFW JstnDFW 3 년 전
Such a good buy this morning! Congrats to those that got in on early trading today.
👍️0
$treet $inatra $treet $inatra 3 년 전
yep, looking great!! back to $35+
👍️0
Roadtojourney Roadtojourney 3 년 전
Kathy wood bought 2.5 milly as well??
👍️0
JstnDFW JstnDFW 3 년 전
Back to 20-30 dollar range here!
👍️0
Wake Setter Wake Setter 3 년 전
ZY good chance for recovery here, great entry for synthetic bio industry. Dramatically oversold - over reaction.
👍️0
ciciagt ciciagt 3 년 전
Yes, news is bad. Softbank and others can’t be pleased. Issues with Hyaline, management shake up, and maybe ‘meager’ revenues in 2022. Pitiful.
👍️0
conix conix 3 년 전
No revenues and no CEO.
👍️0
ciciagt ciciagt 3 년 전
Yikes….
👍️0
Lowjack Lowjack 3 년 전
Did you at least get a chance to bend over first?

Holy CF!
👍️0
ciciagt ciciagt 3 년 전
I own Zymergen and watching a SPAC deal…SRNG and Gingko Bioworks.
https://www.forbes.com/sites/johncumbers/2020/06/25/if-biology-can-build-it-they-will-come-ginkgo-bioworks-is-laying-the-foundation-for-the-4-trillion-bioeconomy/?sh=1ca8193841e0
👍️0
janeyH janeyH 3 년 전
this is in my biosynthetic basket
👍️0
janeyH janeyH 3 년 전
'sup rt?
👍️0
rtrstock rtrstock 4 년 전
I've decided to start focusing on trading Initial Offerings again, it seemed percentage gainwise, to be strategical. So this is my next play.
👍️0

최근 히스토리

NASDAQ
ZY
Zymergen
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

대한민국
회사 소개
사업
Popular
앱 받기
App Store
Google Play

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유